JARISLOWSKY FRASER Ltd raised its holdings in shares of Haleon plc (NYSE:HLN - Free Report) by 8.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 697,108 shares of the company's stock after acquiring an additional 56,615 shares during the period. JARISLOWSKY FRASER Ltd's holdings in Haleon were worth $6,650,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also bought and sold shares of HLN. FMR LLC lifted its stake in shares of Haleon by 3.7% in the 4th quarter. FMR LLC now owns 108,827,814 shares of the company's stock valued at $1,038,217,000 after purchasing an additional 3,909,545 shares during the period. Wellington Management Group LLP lifted its stake in shares of Haleon by 67.5% in the 4th quarter. Wellington Management Group LLP now owns 15,328,325 shares of the company's stock valued at $146,232,000 after purchasing an additional 6,175,835 shares during the period. Envestnet Asset Management Inc. lifted its stake in shares of Haleon by 0.8% in the 4th quarter. Envestnet Asset Management Inc. now owns 7,630,307 shares of the company's stock valued at $72,793,000 after purchasing an additional 58,444 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of Haleon by 18.3% in the 4th quarter. JPMorgan Chase & Co. now owns 6,014,903 shares of the company's stock valued at $57,382,000 after purchasing an additional 930,701 shares during the period. Finally, Northern Trust Corp lifted its stake in shares of Haleon by 27.7% in the 4th quarter. Northern Trust Corp now owns 5,412,542 shares of the company's stock valued at $51,636,000 after purchasing an additional 1,172,931 shares during the period. 6.67% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several research firms recently issued reports on HLN. HSBC reiterated a "hold" rating on shares of Haleon in a research note on Wednesday, March 5th. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Haleon in a report on Monday, March 3rd. Morgan Stanley raised shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price objective on the stock in a report on Friday, May 9th. Hsbc Global Res downgraded shares of Haleon from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 5th. Finally, Barclays reaffirmed an "overweight" rating on shares of Haleon in a report on Tuesday, May 6th. Five research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $11.25.
Check Out Our Latest Research Report on Haleon
Haleon Price Performance
HLN traded down $0.03 during midday trading on Wednesday, hitting $10.43. 6,140,575 shares of the company traded hands, compared to its average volume of 7,870,234. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $47.02 billion, a price-to-earnings ratio of 30.69, a PEG ratio of 2.82 and a beta of 0.24. Haleon plc has a 52-week low of $8.25 and a 52-week high of $10.85. The business has a 50 day simple moving average of $10.21 and a two-hundred day simple moving average of $9.85.
Haleon (NYSE:HLN - Get Free Report) last released its earnings results on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. Haleon had a net margin of 10.85% and a return on equity of 14.76%. The business had revenue of $3.54 billion during the quarter, compared to analyst estimates of $3.38 billion. On average, equities analysts forecast that Haleon plc will post 0.43 earnings per share for the current fiscal year.
Haleon Increases Dividend
The firm also recently announced a -- dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 25th will be issued a dividend of $0.1166 per share. This is a positive change from Haleon's previous -- dividend of $0.05. The ex-dividend date is Friday, April 25th. This represents a dividend yield of 1.6%. Haleon's dividend payout ratio is presently 58.97%.
Haleon Profile
(
Free Report)
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
See Also

Before you consider Haleon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.
While Haleon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.